MANDY FERGUSON: Open Payments
NPI 1760754881 · TAYLORSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 48 payments from 20 companies in 2025. Trend: 2023 $966 · 2024 $888 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $182 |
| ABBVIE INC. | 10 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Lilly USA, LLC | 4 | $66 |
| PFIZER INC. | 2 | $54 |
| Viatris Specialty LLC | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Novo Nordisk Inc | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
Products named: JARDIANCE, VRAYLAR, AIRSUPRA, FARXIGA, BREZTRI, UBRELVY, QULIPTA, YUPELRI.
Industry payments across NC — which companies pay providers there.
